vs

Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and UMH PROPERTIES, INC. (UMH). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $67.0M, roughly 1.1× UMH PROPERTIES, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 8.2%). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.8%).

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

UMH Properties, Inc. is a public equity real estate investment trust (REIT) that owns and operates a portfolio of 135 manufactured home communities with approximately 25,700 developed homesites. These communities are located in 12 states: New Jersey, New York, Ohio, Pennsylvania, Tennessee, Indiana, Michigan, Maryland, Alabama, South Carolina, Georgia, and Florida. UMH also owns and operates two communities in Florida through its joint venture with Nuveen Real Estate.

PBYI vs UMH — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.1× larger
PBYI
$75.5M
$67.0M
UMH
Growing faster (revenue YoY)
PBYI
PBYI
+19.5% gap
PBYI
27.7%
8.2%
UMH
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
7.8%
UMH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PBYI
PBYI
UMH
UMH
Revenue
$75.5M
$67.0M
Net Profit
$4.6M
Gross Margin
69.3%
Operating Margin
22.7%
Net Margin
6.8%
Revenue YoY
27.7%
8.2%
Net Profit YoY
-8.1%
EPS (diluted)
$0.26
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PBYI
PBYI
UMH
UMH
Q4 25
$75.5M
$67.0M
Q3 25
$54.5M
$66.9M
Q2 25
$52.4M
$66.6M
Q1 25
$46.0M
$61.2M
Q4 24
$59.1M
$61.9M
Q3 24
$80.5M
$60.7M
Q2 24
$47.1M
$60.3M
Q1 24
$43.8M
$57.7M
Net Profit
PBYI
PBYI
UMH
UMH
Q4 25
$4.6M
Q3 25
$8.8M
$9.3M
Q2 25
$5.9M
$7.6M
Q1 25
$3.0M
$4.8M
Q4 24
$5.0M
Q3 24
$20.3M
$12.9M
Q2 24
$-4.5M
$5.2M
Q1 24
$-4.8M
$-1.6M
Gross Margin
PBYI
PBYI
UMH
UMH
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
PBYI
PBYI
UMH
UMH
Q4 25
22.7%
Q3 25
17.6%
Q2 25
12.7%
Q1 25
8.7%
Q4 24
22.6%
Q3 24
27.4%
Q2 24
-4.6%
Q1 24
-5.3%
Net Margin
PBYI
PBYI
UMH
UMH
Q4 25
6.8%
Q3 25
16.2%
13.9%
Q2 25
11.2%
11.4%
Q1 25
6.5%
7.9%
Q4 24
8.0%
Q3 24
25.2%
21.3%
Q2 24
-9.6%
8.6%
Q1 24
-11.0%
-2.8%
EPS (diluted)
PBYI
PBYI
UMH
UMH
Q4 25
$0.26
$-0.01
Q3 25
$0.17
$0.05
Q2 25
$0.12
$0.03
Q1 25
$0.06
$0.00
Q4 24
$0.40
$0.00
Q3 24
$0.41
$0.11
Q2 24
$-0.09
$0.01
Q1 24
$-0.10
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PBYI
PBYI
UMH
UMH
Cash + ST InvestmentsLiquidity on hand
$97.5M
$72.1M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$130.3M
$905.5M
Total Assets
$216.3M
$1.7B
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PBYI
PBYI
UMH
UMH
Q4 25
$97.5M
$72.1M
Q3 25
$94.4M
$34.1M
Q2 25
$96.0M
$79.2M
Q1 25
$93.2M
$35.2M
Q4 24
$101.0M
$99.7M
Q3 24
$96.7M
$66.7M
Q2 24
$96.8M
$39.5M
Q1 24
$107.2M
$39.9M
Total Debt
PBYI
PBYI
UMH
UMH
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
PBYI
PBYI
UMH
UMH
Q4 25
$130.3M
$905.5M
Q3 25
$115.3M
$924.7M
Q2 25
$104.7M
$932.0M
Q1 25
$97.1M
$912.4M
Q4 24
$92.1M
$914.0M
Q3 24
$71.1M
$856.5M
Q2 24
$48.5M
$742.0M
Q1 24
$51.0M
$715.1M
Total Assets
PBYI
PBYI
UMH
UMH
Q4 25
$216.3M
$1.7B
Q3 25
$202.9M
$1.6B
Q2 25
$194.9M
$1.6B
Q1 25
$196.2M
$1.5B
Q4 24
$213.3M
$1.6B
Q3 24
$220.7M
$1.5B
Q2 24
$205.0M
$1.4B
Q1 24
$214.1M
$1.4B
Debt / Equity
PBYI
PBYI
UMH
UMH
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PBYI
PBYI
UMH
UMH
Operating Cash FlowLast quarter
$14.4M
$82.0M
Free Cash FlowOCF − Capex
$14.4M
FCF MarginFCF / Revenue
19.1%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
17.92×
TTM Free Cash FlowTrailing 4 quarters
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PBYI
PBYI
UMH
UMH
Q4 25
$14.4M
$82.0M
Q3 25
$9.7M
$23.4M
Q2 25
$14.1M
$24.4M
Q1 25
$3.6M
$12.8M
Q4 24
$15.6M
$81.6M
Q3 24
$11.0M
$16.7M
Q2 24
$1.0M
$18.6M
Q1 24
$11.2M
$19.0M
Free Cash Flow
PBYI
PBYI
UMH
UMH
Q4 25
$14.4M
Q3 25
$9.7M
Q2 25
$14.1M
Q1 25
$3.6M
Q4 24
$15.6M
Q3 24
$11.0M
Q2 24
$1.0M
Q1 24
FCF Margin
PBYI
PBYI
UMH
UMH
Q4 25
19.1%
Q3 25
17.7%
Q2 25
26.8%
Q1 25
7.7%
Q4 24
26.4%
Q3 24
13.7%
Q2 24
2.1%
Q1 24
Capex Intensity
PBYI
PBYI
UMH
UMH
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.0%
Q1 25
0.1%
Q4 24
0.0%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
PBYI
PBYI
UMH
UMH
Q4 25
17.92×
Q3 25
1.10×
2.53×
Q2 25
2.41×
3.21×
Q1 25
1.21×
2.66×
Q4 24
16.39×
Q3 24
0.54×
1.30×
Q2 24
3.58×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons